Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 2 of 38
A Study of Multiparametric Ultrasound Imaging Methods
NCT07270237
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
NCT07231952
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
NCT07227636
A Dietary Study for People With Multiple Myeloma
NCT07226609
A Study of 177Lu-PSMA-617 in People With Gliomas
NCT07223034
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
NCT07220967
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
NCT07223021
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer
NCT07218250
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
NCT07218601
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
NCT07209449
A Study of Questionnaires in Adolescents and Young Adults With Cancer
NCT07212166
Study of How People Make Decisions About Prostate Cancer Risk
NCT07197723
A Study of Surgery and Radiotherapy in People With Breast Cancer
NCT07053085
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
NCT07144800
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
NCT07137494
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
NCT07082868
A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma
NCT07030699
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
NCT07105059
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
NCT07001384
A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) Tongue Strength Trainer in People With Oral Tongue Cance
NCT07124520
A Study of Tarlatamab for People With Prostate Cancer
NCT07111507
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
NCT07099391
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
NCT07117461
A Study of Herbal Supplements in Cancer Survivors With Constipation
NCT07091084
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
NCT07063212
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
NCT07052916
A Study of Revaree Plus in People With Breast Cancer
NCT07042581
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
NCT07029217
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
NCT06903702
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
NCT07011004
COBRA: Cancer, Older Adults, Balance and Resistance Activities
NCT07011862
A Study of Time-Restricted Eating in Childhood Cancer Survivors
NCT07009288
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
NCT07006506
A Study of Changes to Prostate Procedures
NCT06986083
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
NCT06984861
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
NCT06954337
A Study of ERAS-601 in People With Chordoma
NCT06957327
A Study of Hospital-at-Home for People Receiving Tarlatamab
NCT06957314
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
NCT06929286
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
NCT06934889
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT06925724
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
NCT06915116
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
NCT06891560
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)
NCT06873815
A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer
NCT06863233
A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma
NCT06843434
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
NCT06843967
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
NCT06835972
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
NCT06699602
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.